{"database": "lobbying", "table": "lobbying_activities", "rows": [[628190, "32e29923-807b-4187-9d8f-7d990385343e", "Q2", "THE PETRIZZO GROUP, INC.", 305932, "SEATTLE BIOMEDICAL RESEARCH INSTITUTE", 2008, "second_quarter", "MED", "Secure funding to enable SBRI to acquire critical technologies and associated equipment to ensure that its TB drug discovery research delivers on its ultimate goal to shorten the course of TB treatment from 6-9 months down to 2-4 weeks while streamlining the current four-drug treatment regimen.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2008-07-15T11:38:56-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["628190"], "units": {}, "query_ms": 17.939662095159292, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}